Clin2
NCT07768813Likely a fitNot yet recruiting

Comparing two versions of an injected drug in healthy and overweight people

HealthyObesity

Part of Hormones & metabolism clinical trials.

This trial compares two different versions of an injected study drug (survodutide) to see how they are absorbed by the body. It is open to healthy people and people with overweight or obesity, and it may help researchers find a better way to deliver this treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
44 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are 18 to 55 years old.
  • You are generally healthy, or you have overweight or obesity.
  • Your body mass index (BMI) is between 22 and 39.9.
  • You are willing to give written informed consent.
  • You have no major health conditions that are not well controlled.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07754474Not yet recruiting· Phase 1
Testing a new medicine for overweight or obesity

This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.

Mannheim
NCT07407348Recruiting· Phase 1
Comparing Two Forms of Survodutide in People with Overweight or Obesity

This trial compares how two different forms of the study drug survodutide are absorbed by the body in people with overweight or obesity. It helps doctors understand which version works better.

Nottingham
NCT07337174Not yet recruiting· Phase 1
Comparing two versions of an injected medicine in healthy adults

This trial tests two forms of an injected medication, HUC2-676 and HUC2-676-R, to see how safe they are and how the body processes them. It is for healthy adults who want to help compare these treatments.

NCT07716241Not yet recruiting· Phase 1
Study of HS-20136-2 for healthy or obese adults

This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.

Hefei
NCT07467447Recruiting· Phase 2
Testing a weight-loss drug for people with obesity or overweight

This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.

Shenzhen, Guangdong
NCT07291232Recruiting· Phase 1
Study of an injected drug for adults with obesity

This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.

Anaheim, California

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.